Последние добавленные видео:
Medicines:-Fedratinib
-
5 years ago
145 5 years ago 2:36Case 1: Fedratinib Treatment for Myelofibrosis
-
5 years ago
491 5 years ago 5:10Fedratinib in MF: JAKARTA2 and FREEDOM Trials
-
5 years ago
314 5 years ago 7:43The Role of Fedratinib in Myelofibrosis
-
5 years ago
394 5 years ago 1:10Fedratinib Reemerges as FDA-Approved Treatment of Myelofibrosis
-
4 years ago
117 4 years ago 4:46Fedratinib for Primary Myelofibrosis
-
2 years ago
225 2 years ago 1:22Real-world outcomes of patients with MF treated with fedratinib post-ruxolitinib discontinuation
-
2 years ago
76 2 years ago 2:09The role of fedratinib in MF and the impact of this agent in the field
-
4 years ago
80 4 years ago 1:27JAKARTA and JAKARTA2: OS and PFS analysis of fedratinib in myelofibrosis
-
5 years ago
173 5 years ago 1:40Considering Fedratinib or Ruxolitinib in the Frontline Setting for Treatment of Myelofibrosis
-
5 years ago
65 5 years ago 3:09Key Data for the Use of Fedratinib in MF
-
5 months ago
62 5 months ago 1:53Efficacy and safety of fedratinib in patients with myelofibrosis and low platelet counts
-
5 years ago
141 5 years ago 2:07Fedratinib for myelofibrosis
-
5 years ago
118 5 years ago 1:29Dr. Mesa on the FDA Approval of Fedratinib in Myelofibrosis
-
5 years ago
89 5 years ago 1:12Dr. Kuykendall on the Approval of Fedratinib in Myelofibrosis
-
5 years ago
540 5 years ago 1:42Dr. Mesa on Ruxolitinib Vs Fedratinib in Myelofibrosis Treatment
-
5 years ago
329 5 years ago 1:54JAKARTA-2 Reanalysis Demonstrates Activity With Fedratinib in MF After Ruxolitinib Failure
-
6 years ago
1048 6 years ago 3:52Comparison of Ruxolitinib vs Fedratinib and Practical Implications
-
5 years ago
68 5 years ago 1:22JAKARTA2 update: fedratinib in MF patients previously treated with ruxolitinib